RESUMEN
INTRODUCTION: Extracorporeal Membrane Oxygenation (ECMO) may be used in the setting of pregnancy or the peripartal period, however its utility has not been well-characterized. This study aims to give an overview on the prevalence of peripartel ECMO cases and further assess the indications and outcomes of ECMO in this setting across multiple centers and countries. METHODS: A retrospective, multicenter, international cohort study of pregnant and peripartum ECMO cases was performed. Data were collected from six ECMO centers across three continents over a 10-year period. RESULTS: A total of 60 pregnany/peripartal ECMO cases have been identified. Most frequent indications are acute respiratory distress syndrome (n = 30) and pulmonary embolism (n = 5). Veno-venous ECMO mode was applied more often (77%). ECMO treatment during pregnancy was performed in 17 cases. Maternal and fetal survival was high with 87% (n = 52), respectively 73% (n = 44). CONCLUSIONS: Various emergency scenarios during pregnancy and at time of delivery may require ECMO treatment. Peripartal mortality in a well-resourced setting is rare, however emergencies in the labor room occur and knowledge of available rescue therapy is essential to improve outcome. Obstetricians and obstetric anesthesiologists should be aware of the availability of ECMO resource at their hospital or region to ensure immediate contact when needed.
Asunto(s)
Oxigenación por Membrana Extracorpórea , Embolia Pulmonar , Síndrome de Dificultad Respiratoria , Embarazo , Femenino , Humanos , Estudios Retrospectivos , Estudios de Cohortes , Síndrome de Dificultad Respiratoria/terapiaRESUMEN
Veno-venous extracorporeal membrane oxygenation is indicated in patients with acute respiratory distress syndrome and severely impaired gas exchange despite evidence-based lung protective ventilation, prone positioning and other parts of the standard algorithm for treating such patients. Extracorporeal support can facilitate ultra-lung-protective ventilation, meaning even lower volumes and pressures than standard lung-protective ventilation, by directly removing carbon dioxide in patients needing injurious ventilator settings to maintain sufficient gas exchange. Injurious ventilation results in ventilator-induced lung injury, which is one of the main determinants of mortality in acute respiratory distress syndrome. Marked reductions in the intensity of ventilation to the lowest tolerable levels under extracorporeal support may be achieved and could thereby potentially mitigate ventilator-induced lung injury and theoretically patient self-inflicted lung injury in spontaneously breathing patients with high respiratory drive. However, the benefits of this strategy may be counterbalanced by the use of continuous deep sedation and even neuromuscular blocking drugs, which may impair physical rehabilitation and impact long-term outcomes. There are currently a lack of large-scale prospective data to inform optimal invasive ventilation practices and how to best apply a holistic approach to patients receiving veno-venous extracorporeal membrane oxygenation, while minimising ventilator-induced and patient self-inflicted lung injury. We aimed to review the literature relating to invasive ventilation strategies in patients with acute respiratory distress syndrome receiving extracorporeal support and discuss personalised ventilation approaches and the potential role of adjunctive therapies in facilitating lung protection.
Asunto(s)
Oxigenación por Membrana Extracorpórea , Síndrome de Dificultad Respiratoria , Lesión Pulmonar Inducida por Ventilación Mecánica , Oxigenación por Membrana Extracorpórea/métodos , Humanos , Estudios Prospectivos , Respiración Artificial/métodos , Síndrome de Dificultad Respiratoria/terapia , Lesión Pulmonar Inducida por Ventilación Mecánica/prevención & controlRESUMEN
BACKGROUND: Patients treated in Australian intensive care units (ICUs) have an overall mortality rate of 5.05%. This is due to the critical nature of their disease, the increasing proportion of patients with multiple comorbidities, and advanced age. This has made treating patients during the end of life an integral part of intensive care practice and requires a high quality of care. With the increased use of electronic clinical information systems, a standardised protocol encompassing end-of-life care may provide an efficient method for documentation, communication, and timely delivery of comfort care. OBJECTIVE: The aim of the study was to determine if an electronic clinical information system-based end-of-life care protocol improved nurses' satisfaction with the practice of end-of-life care for patients in the ICU. DESIGN: This is a prospective single-centre observational study. SETTING: The study was carried out at a 20-bed cardiothoracic and general ICU between 2015 and 2017. PARTICIPANTS: The study participants were ICU nurses. INTERVENTION: Electronic clinical information-based end-of-life care protocol was used in the study. OUTCOME: The primary outcome was nurse satisfaction obtained by a survey. RESULTS: The number of respondents for the before survey and after survey was 58 (29%) and 64 (32%), respectively. There was a significant difference between the before survey and the after survey with regard to feeling comfortable in transitioning from curative treatment (median = 2 [interquartile range {IQR} = 2, 3] vs 3 [IQR = 2, 3], p = 0.03), feeling involved in the decision to move from curative treatment to end-of-life care (median = 2 [IQR = 2, 2] vs 2 [IQR 2, 3], p = 0.049), and feeling religious beliefs/rituals should be respected during the end-of-life process (median = 4 [IQR = 3, 4] vs. 4 [IQR = 4, 4], p = 0.02). There were some practices that had a low satisfaction rate on both the before survey and after survey. However, a high proportion of nurses were satisfied with many of the end-of-life care practices. CONCLUSION: The nurses were highly satisfied with many aspects of end-of-life care practices in this unit. The use of an electronic clinical information system-based protocol improved nurse satisfaction and perception of quality of end-of-life care practices for three survey questions.
Asunto(s)
Satisfacción Personal , Cuidado Terminal , Australia , Humanos , Sistemas de Información , Unidades de Cuidados Intensivos , Estudios Observacionales como Asunto , Estudios Prospectivos , Encuestas y CuestionariosRESUMEN
BACKGROUND: Oxidative stress from surgery or critically illness has been shown to adversely contribute to morbidity and mortality. Recent studies record that oxidative stress is heightened following packed red blood cell (PRBC) transfusions and that products of oxidative stress accumulate as the PRBC ages. However, there are no studies that investigate if transfusion of aged PRBC actually increases the recipient's oxidative stress profile more than fresh PRBC. OBJECTIVE: To compare the effect of fresh vs aged PRBC transfusions on the recipient's oxidative stress using an ovine model. MATERIALS AND METHODS: Male sheep were transfused with either fresh (n = 6) or aged (n = 6) ovine PRBC, and serial blood samples taken. Plasma samples were analysed for lipid peroxidation using the thiobarbituric acid reactive substances (TBARS) assay. This served as an indicator of oxidative injury. Antioxidant function and trace element levels were also measured. RESULTS: Like human PRBC, the ovine PRBC had negligible selenium levels. Irrespective of age, PRBC transfusion was associated with reduced selenium levels and antioxidant function, which correlated with increased markers of lipid peroxidation. CONCLUSION: Transfusion of selenium poor PRBC can dilute selenium levels and compromise glutathione peroxidase antioxidant activity and thereby allow lipid peroxidation. As there was no evidence that aged PRBC induced more severe oxidative injury this suggests that selenium dilution is a key underlying mechanism. Further studies are needed to assess the impact of transfusion-related oxidative stress in massive transfusions.
Asunto(s)
Transfusión de Eritrocitos , Peroxidación de Lípido , Modelos Biológicos , Estrés Oxidativo , Selenio/sangre , Animales , Conservación de la Sangre/efectos adversos , Humanos , Masculino , Ovinos , Factores de TiempoRESUMEN
BACKGROUND AND OBJECTIVES: Transfusion of blood products in particular older products is associated with patient morbidity. Previously, we demonstrated a higher incidence of acute lung injury in lipopolysaccharide-treated sheep transfused with stored blood products. As transfusion following haemorrhage is more common, we aimed to determine whether a 'first hit' of isolated haemorrhage would precipitate similar detrimental effects following transfusion and also disrupt haemostasis. MATERIALS AND METHODS: Anaesthetized sheep had 33% of their total blood volume collected into Leukotrap bags (Pall Medical), which were processed into packed red blood cells and cross-matched for transfusion into other sheep. After 30 mins, the sheep were resuscitated with either: fresh (<5 days old) or stored (35-42 days old) ovine blood followed by 4% albumin to replacement volume, albumin alone or normal saline alone and monitored for 4 h. RESULTS: The first hit of haemorrhage precipitated substantial decreases in mean arterial pressure however haemostasis was preserved. Transfusion of stored ovine blood induced (1) transient pulmonary arterial hypertension but no oedema and (2) reduced fibrinogen levels more than fresh blood, but neither induced coagulopathy. Thus, transfusion of stored blood affected pulmonary function even in the absence of overt organ injury. CONCLUSION: The fact that stored blood transfusions: (1) did not induce acute lung injury in contrast to previous lipopolysaccharide-primed animal models identifies the 'first hit' as an important determinant of the severity of transfusion-mediated injury; (2) impaired pulmonary dynamics verifies the sensitivity and vulnerability of the pulmonary system to injury.
Asunto(s)
Conservación de la Sangre , Transfusión de Eritrocitos , Hemorragia , Hipertensión Pulmonar , Lesión Pulmonar Aguda/sangre , Lesión Pulmonar Aguda/etiología , Animales , Modelos Animales de Enfermedad , Hemorragia/sangre , Hemorragia/fisiopatología , Hemorragia/terapia , Hipertensión Pulmonar/sangre , Hipertensión Pulmonar/fisiopatología , Hipertensión Pulmonar/terapia , Masculino , Ovinos , Factores de TiempoRESUMEN
A novel cationic porphyrin-quinoxaline conjugate 8 was prepared in good yield by the coupling of activated quinoxaline carboxylic acid 5 with an appropriate aminoporphyrin. The UV-vis spectra of conjugate 8 with the addition of ctDNA shows substantial hypochromicity (39%) and a red shift (12 nm) in the Soret band indicating intercalation and self stacking along the surface. The binding constant of conjugate 8 with ctDNA was determined to be 1.26×10(6) M(-1). The porphyrin-quinoxaline conjugate 8 displayed enhanced photocytotoxicity (IC50=0.06 µM) when compared to TMPyP against A549 cancer cells.
Asunto(s)
Antineoplásicos/química , Porfirinas/química , Quinoxalinas/química , Animales , Antineoplásicos/síntesis química , Antineoplásicos/toxicidad , Cationes/química , Bovinos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , ADN/química , ADN/metabolismo , División del ADN/efectos de los fármacos , Humanos , Porfirinas/síntesis química , Porfirinas/toxicidad , Quinoxalinas/síntesis química , Quinoxalinas/toxicidad , Espectrometría de Fluorescencia , Rayos UltravioletaRESUMEN
A Cu(i)-catalyzed azide-alkyne cycloaddition reaction (CuAAC) has been utilized to prepare novel triazole-linked cationic porphyrin-psoralen conjugates that exhibited significant photocytotoxicity against A549 cancer cells (IC50 = 84 nM).
Asunto(s)
ADN/química , Ficusina/síntesis química , Porfirinas/síntesis química , Antineoplásicos/síntesis química , Antineoplásicos/química , Antineoplásicos/farmacología , Catálisis , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Cobre/química , Ficusina/química , Ficusina/farmacología , Fluorescencia , Humanos , Concentración 50 Inhibidora , Estructura Molecular , Porfirinas/química , Porfirinas/farmacologíaRESUMEN
Extracorporeal membrane oxygenation (ECMO) facilitates organ support in patients with refractory cardiorespiratory failure whilst disease-modifying treatments can be administered. Improvements to the ECMO process have resulted in its increased utilisation. However, iatrogenic injuries remain, with bleeding and thrombosis the most significant concerns. Many factors contribute to the formation of thrombi, with the hyperoxaemia experienced during ECMO a potential contributor. Outside of ECMO, emerging evidence associates hyperoxaemia with increased mortality. Currently, no universal definition of hyperoxaemia exists, a gap in clinical standards that may impact patient outcomes. Hyperoxaemia has the potential to induce platelet activation, aggregation and, subsequently, thrombosis through markedly increasing the production of reactive oxygen species. There are minimal data in the current literature that explore the relationship between ECMO-induced hyperoxaemia and the production of reactive oxygen species - a putative link towards pathology. Furthermore, there is limited research directly linking hyperoxaemia and platelet activation. These are areas that warrant investigation as definitive data regarding the nascence of these pathological processes may delineate and define the relative risk of supranormal oxygen tension. These data could then assist in defining optimal oxygenation practice, reducing the risks associated with extracorporeal support.
Asunto(s)
Oxigenación por Membrana Extracorpórea/efectos adversos , Hiperoxia , Hemorragia/etiología , Hemorragia/metabolismo , Hemorragia/mortalidad , Humanos , Hiperoxia/etiología , Hiperoxia/metabolismo , Hiperoxia/mortalidad , Agregación Plaquetaria , Especies Reactivas de Oxígeno/metabolismo , Factores de Riesgo , Trombosis/etiología , Trombosis/metabolismo , Trombosis/mortalidadRESUMEN
INTRODUCTION: Management of the airway in the perioperative period for patients requiring major head and neck ablative surgery has commonly included the performance of elective surgical tracheostomy. This has been standard practice in most maxillofacial units across the UK, including ours. However, the COVID-19 pandemic and emerging guidelines on aerosol-generating procedures required us to revisit the need for a perioperative tracheostomy. METHODS: We present our series of 29 consecutive cases, cared for during the first wave of the COVID-19 pandemic, that were managed either using surgical tracheostomy or overnight tracheal intubation. RESULTS: Out of 29 patients 3 received a surgical tracheostomy. The average duration of tracheostomy use was 8 days. Twenty patients were managed using a period of overnight tracheal intubation. Average duration of tracheal intubation was 1.2 days, with an average intensive care unit stay of 1.7 days. The average duration of hospital stay was 15.8 days for patients managed with overnight tracheal intubation and 30.1 days for patients who received a surgical tracheostomy. The return to theatre rate was 13.8% for reasons including flap failure and neck space infection. There were no airway issues reported in this series of patients. CONCLUSIONS: Our findings suggest that overnight tracheal intubation can be a safe alternative to surgical tracheostomy in the majority of cases.
Asunto(s)
COVID-19 , Traqueostomía , Humanos , Traqueostomía/métodos , COVID-19/epidemiología , Pandemias , Estudios Retrospectivos , Intubación Intratraqueal/métodosRESUMEN
Mortality during pregnancy in a well-resourced setting is rare, but acute pulmonary embolism is one of the leading causes. We present the successful use of extracorporeal cardiopulmonary resuscitation (eCPR) in a 22-year old woman who experienced cardiopulmonary collapse following urgent caesarean section in the setting of a sub-massive pulmonary embolus. Resources and personnel to perform eCPR were not available at the maternity hospital and were recruited from an adjacent pediatric hospital. Initial care used low blood flow extracorporeal membrane oxygenation (ECMO) with pediatric ECMO circuitry, which was optimized when the team from a nearby adult cardiac hospital arrived. Following ECMO support, the patient experienced massive hemorrhage which was managed with uterotonic agents, targeted transfusion, bilateral uterine artery embolisation and abdominal re-exploration. The patient was transferred to an adult unit where she remained on ECMO for five days. She was discharged home with normal cognitive function. This case highlights the role ECMO plays in providing extracorporeal respiratory or mechanical circulatory support in a high risk obstetric patient.
Asunto(s)
Reanimación Cardiopulmonar/métodos , Oxigenación por Membrana Extracorpórea/métodos , Periodo Posparto , Embolia Pulmonar/terapia , Angiografía , Transfusión Sanguínea , Embolectomía , Femenino , Frecuencia Cardíaca Fetal , Humanos , Embarazo , Embolia Pulmonar/diagnóstico por imagen , Embolia Pulmonar/cirugía , Adulto JovenRESUMEN
BACKGROUND/OBJECTIVES: Post-operative atrial fibrillation (POAF) is a frequent complication of cardiac surgery. Oxidative stress and reduced antioxidant function have major roles in its development. Selenium is a key to normal antioxidant function, and levels are often low before cardiac surgery. This study investigated whether low preoperative selenium levels were associated with POAF in cardiac surgical patients. SUBJECTS/METHODS: Using the Society of Thoracic Surgeons (STS) Mortality risk score, 50 patients having primary coronary artery bypass grafts (CABG) surgery were divided into two groups: (i) low-risk group (STS ⩽0.5%; n=26) and (ii) intermediate-risk group (STS ⩾2.0%; n=24). Plasma levels of selenium, glutathione peroxidase (GPx) and malondialdehyde (MDA) were measured in all patients at anaesthetic induction, after aortic cross-clamp removal, 3 h post cardiopulmonary bypass and on post-operative days 1 and 5. Multiple logistic regression was used to assess whether selenium levels were associated with POAF development. RESULTS: Seventeen patients developed POAF (14 patients in the intermediate-risk group and 3 patients in the low-risk group). Preoperative selenium was lower in patients who developed POAF compared with those with normal sinus rhythm (0.73±0.16 vs 0.89±0.13 µmol/l, P=0.005), and this was independently associated with POAF (PR 0.32; 95% confidence credible interval (95%cI) 0.06-0.85, P=0.016). Regardless of POAF, preoperative selenium was lower in the intermediate-risk patients than in the low-risk patients (0.77±0.15 vs 0.89±0.14 µmol/l; P=0.004). CONCLUSIONS: Intermediate-risk patients with low preoperative selenium levels may be at a greater risk of developing POAF following CABG. This raises the question of whether selenium supplementation in select cardiac surgical patients may reduce their POAF risk.
Asunto(s)
Fibrilación Atrial/mortalidad , Enfermedad de la Arteria Coronaria/cirugía , Selenio/sangre , Anciano , Fibrilación Atrial/sangre , Puente de Arteria Coronaria , Enfermedad de la Arteria Coronaria/sangre , Enfermedad de la Arteria Coronaria/patología , Femenino , Humanos , Modelos Logísticos , Masculino , Complicaciones Posoperatorias/sangre , Complicaciones Posoperatorias/mortalidad , Cuidados Preoperatorios , Estudios Prospectivos , Queensland , Índice de Severidad de la EnfermedadRESUMEN
An imported case of Schistosoma haematobium infection presenting with haematuria and proteinuria is described. This would constitute a first case of urinary schistosomiasis in Malaysia. The patient failed to respond to multiple antibiotic treatment and was successfully treated with praziquantel.
Asunto(s)
Esquistosomiasis Urinaria , Niño , Femenino , Hematuria/etiología , Humanos , Malasia , Praziquantel/uso terapéutico , Proteinuria/etiología , Esquistosomiasis Urinaria/diagnóstico , Esquistosomiasis Urinaria/tratamiento farmacológicoRESUMEN
Employing a click chemistry approach we have synthesized a novel triazole-linked cationic porphyrin-ß-carboline conjugate which exhibited remarkable photocytotoxicity against the A549 cancer cell line (IC(50) = 60 nM).
Asunto(s)
Antineoplásicos/farmacología , Carbolinas/farmacología , Metaloporfirinas/farmacología , Porfirinas/farmacología , Zinc/química , Línea Celular Tumoral , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Metaloporfirinas/síntesis química , Fotoquimioterapia , Triazoles/farmacologíaRESUMEN
Organ transplantation is a viable therapeutic option for patients with endstage organ failure when other therapies have been exhausted. Donation after cardiac death (DCD) is re-emerging as a potential option to expand the donor pool to meet an increasing demand for organ transplantation. In this review, we evaluate the evolution of the Queensland DCD pilot project since its inception in August 2008. A retrospective analysis of registry data from Australia and New Zealand Organ Donation (ANZOD) and DonateLife Queensland was performed to collect information relating to donor characteristics, DCD process and outcomes. Data was compared with the ANZOD registry annual reports from 2008 to 2010. Twenty-three (82%) out of 28 potential DCD organ donors were successful in donating their organs. The median time from presentation to reaching consensus to withdraw cardiorespiratory support was four days (interquartile range three to eight days). The median time from withdrawal to death was 20 minutes (interquartile range 18 to 25 minutes), and the median warm ischaemia time was 17 minutes (interquartile range 14 to 19 minutes). DCD donors represented 16% (23) of the 144 deceased donors over the study period and provided approximately 10% (48) of the 505 deceased organs in Queensland. The DCD pilot project resulted in an increase in solid organ transplantation in Queensland. It allowed the development of policies to facilitate DCD, in accordance with state's legislation and DonateLife practices. If implemented state-wide, the program has the potential to be an effective way to improve organ donation rates in Queensland.
Asunto(s)
Muerte , Trasplante de Órganos/estadística & datos numéricos , Donantes de Tejidos , Adolescente , Adulto , Anciano , Femenino , Guías como Asunto , Promoción de la Salud , Cardiopatías , Trasplante de Corazón/estadística & datos numéricos , Humanos , Trasplante de Riñón/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Queensland , Estudios Retrospectivos , Adulto JovenRESUMEN
Zygomatic complex fractures make up approximately 60% of facial fractures. The vast majority treated surgically use titanium miniplates. These require longer operating times and facial incisions to access the fracture. The use of a K-wire was first described 60 years ago. As a new generation of surgeons emerges, it is important to be aware of the various techniques available to increase their surgical armamentarium. One of its benefits is that it has a significantly reduced operative time and does not require any incisions.
Asunto(s)
Hilos Ortopédicos , Fijación Interna de Fracturas/instrumentación , Fracturas Cigomáticas/cirugía , Accidentes por Caídas , Anciano , Humanos , MasculinoRESUMEN
Critically ill patients receiving extracorporeal membrane oxygenation (ECMO) are often noted to have increased sedation requirements. However, data related to sedation in this complex group of patients is limited. The aim of our study was to characterise the sedation requirements in adult patients receiving ECMO for cardiorespiratory failure. A retrospective chart review was performed to collect sedation data for 30 consecutive patients who received venovenous or venoarterial ECMO between April 2009 and March 2011. To test for a difference in doses over time we used a regression model. The dose of midazolam received on ECMO support increased by an average of 18 mg per day (95% confidence interval 8, 29 mg, P=0.001), while the dose of morphine increased by 29 mg per day (95% confidence interval 4, 53 mg, P=0.021) The venovenous group received a daily midazolam dose that was 157 mg higher than the venoarterial group (95% confidence interval 53, 261 mg, P=0.005). We did not observe any significant increase in fentanyl doses over time (95% confidence interval 1269, 4337 µg, P=0.94). There is a significant increase in dose requirement for morphine and midazolam during ECMO. Patients on venovenous ECMO received higher sedative doses as compared to patients on venoarterial ECMO. Future research should focus on mechanisms behind these changes and also identify drugs that are most suitable for sedation during ECMO.
Asunto(s)
Oxigenación por Membrana Extracorpórea , Insuficiencia Cardíaca/terapia , Hipnóticos y Sedantes/administración & dosificación , Midazolam/administración & dosificación , Insuficiencia Respiratoria/terapia , APACHE , Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
Kuttner tumour is benign, chronic, sclerosing sialadenitis that usually occurs in the submandibular gland and is regarded as a salivary gland neoplasm because of its clinical features. We describe a tumour arising from a minor salivary gland of the upper lip. To our knowledge, there are only two previously reported cases.
Asunto(s)
Neoplasias de los Labios/patología , Neoplasias de las Glándulas Salivales/patología , Glándulas Salivales Menores/patología , Enfermedad Crónica , Diagnóstico Diferencial , Femenino , Humanos , Neoplasias de los Labios/complicaciones , Neoplasias de los Labios/cirugía , Persona de Mediana Edad , Neoplasias de las Glándulas Salivales/complicaciones , Neoplasias de las Glándulas Salivales/cirugía , Glándulas Salivales Menores/cirugía , Sialadenitis/diagnóstico , Sialadenitis/etiologíaRESUMEN
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder. Histologically the lesion has a fragile capillary bed that could result in a catastrophic bleed after a minor injury, as in this case.
Asunto(s)
Obstrucción de las Vías Aéreas/etiología , Traumatismos del Cuello/complicaciones , Heridas no Penetrantes/complicaciones , Adolescente , Arteria Carótida Externa/patología , Descompresión Quirúrgica , Femenino , Neoplasias de Cabeza y Cuello/complicaciones , Hematoma/etiología , Hemorragia/etiología , Humanos , Neurofibromatosis 1/complicaciones , Tomografía Computarizada por Rayos X , Trismo/etiologíaRESUMEN
The authors present an unusual case of invasive squamous cell carcinoma (SCC) developing in a pre-existing plasmacytosis of the lip. The roles of chronic inflammation, immunosuppression, and smoking in the pathogenesis of this tumour are briefly discussed. The authors highlight a significant side effect of the use of immunosuppressive drugs in benign conditions.